Doxycycline Injection, Powder, For Solution
Product Images NDC 0143-9381

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxycycline (NDC 0143-9381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxycycline Structural Formula (Doxycycline For Injection Usp 1)

Chemical structure of doxycycline, depicting its molecular configuration including multiple hydroxyl, methyl, and amide groups, along with associated forms such as two hydrochloride molecules, one water molecule, and one ethanol molecule in the complex.*

FDA Label Image

Plb426-wes.2 (Doxycycline For Injection Usp 2)

Label for Doxycycline 100 mg per vial injection, USP, a lyophilized powder for intravenous infusion, requiring dilution and reconstitution. Manufactured by Hikma Farmacêutica with distribution by Hikma Pharmaceuticals USA Inc. The label includes storage instructions, dosage form, preservative information, and NDC 0143-9381.*

FDA Label Image

Plb462-wes.1 (Doxycycline For Injection Usp 3)

Label for Doxycycline for Injection, USP 100 mg per vial, a powder for solution dosage form intended for intravenous infusion. The label specifies it is sterile, preservative-free, and must be diluted prior to use. The product contains doxycycline hyclate equivalent to 100 mg doxycycline per vial and is distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Serialization Image (Doxycycline For Injection Usp 4)

Doxycycline injection powder for solution label showing manufacturing details including GTIN, serial number, expiration date placeholder, and lot number. The label is associated with Hikma Pharmaceuticals USA Inc. and corresponds to the 100 mg/1 intravenous powder dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.